AbbVie Turnaround Lurking After The Correction Pain - Seeking Alpha
| ABBV34 Stock | BRL 66.96 0.49 0.74% |
About 52% of AbbVie's investor base is interested to short. The analysis of current outlook of investing in AbbVie Inc suggests that many traders are impartial regarding AbbVie's prospects. The current market sentiment, together with AbbVie's historical and current headlines, can help investors time the market. In addition, many technical investors use AbbVie Inc stock news signals to limit their universe of possible portfolio assets.
AbbVie |
AbbVie Turnaround Lurking After The Correction Pain Seeking Alpha
Read at news.google.com
 |
AbbVie Fundamental Analysis
We analyze AbbVie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
AbbVie is rated fifth in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
AbbVie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AbbVie stock to make a market-neutral strategy. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics with similar companies.
Peers
AbbVie Related Equities
| BIIB34 | Biogen | 1.05 | ||||
| ABBV34 | AbbVie | 0.74 | ||||
| JNJB34 | Johnson Johnson | 0.79 | ||||
| GILD34 | Gilead Sciences | 1.04 | ||||
| MRCK34 | Merck | 1.11 |
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |